Terms: = Thyroid cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Prognosis
9 results:
1. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
[TBL] [Abstract] [Full Text] [Related]
2. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
3. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated thyroid cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract] [Full Text] [Related]
4. Methylation of tumour suppressor genes associated with thyroid cancer.
Botezatu A; Iancu IV; Plesa A; Manda D; Popa O; Bostan M; Mihaila M; Albulescu A; Fudulu A; Vladoiu SV; Huica I; Dobrescu R; Anton G; Badiu C
Cancer Biomark; 2019; 25(1):53-65. PubMed ID: 31006665
[TBL] [Abstract] [Full Text] [Related]
5. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract] [Full Text] [Related]
6. Time to Separate Persistent From Recurrent Differentiated thyroid cancer: Different Conditions With Different Outcomes.
Sapuppo G; Tavarelli M; Belfiore A; Vigneri R; Pellegriti G
J Clin Endocrinol Metab; 2019 Feb; 104(2):258-265. PubMed ID: 30165559
[TBL] [Abstract] [Full Text] [Related]
7. Imbalance in DNA repair machinery is associated with BRAF
Lutz BS; Leguisamo NM; Cabral NK; Gloria HC; Reiter KC; Agnes G; Zanella V; Meyer ELS; Saffi J
Mol Cell Endocrinol; 2018 Sep; 472():140-148. PubMed ID: 29229408
[TBL] [Abstract] [Full Text] [Related]
8. [Specificities of carcinomas in adolescents and young adults].
Fresneau B; Dourthe ME; Jouin A; Laurence V; de Lambert G; Colas C; Coret M; Laprie A; Rebours C; Orbach D; Demoor-Goldschmidt C
Bull Cancer; 2017 Mar; 104(3):267-280. PubMed ID: 27989630
[TBL] [Abstract] [Full Text] [Related]
9. VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.
Schafroth C; Galván JA; Centeno I; Koelzer VH; Dawson HE; Sokol L; Rieger G; Berger MD; Hädrich M; Rosenberg R; Nitsche U; Schnüriger B; Langer R; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Dec; 6(39):41453-63. PubMed ID: 26496026
[TBL] [Abstract] [Full Text] [Related]
